Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Company    BMY

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société BRISTOL-MYERS SQUIBB COMPA
05/29BRISTOL MYERS SQUIBB : to Hold Virtual Three-Part Investor Series
BU
05/28BRISTOL MYERS SQUIBB : Receives European Commission Approval for Zeposia for the..
AQ
05/28TCR-2 Therapeutics Hires Key Business Development and Regulatory Affairs Cell..
AQ
05/27BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo + Yervo..
AQ
05/27BRISTOL MYERS SQUIBB : Receives European Commission Approval for Zeposia (ozanim..
BU
05/26BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo® (nivol..
BU
05/25BRISTOL MYERS SQUIBB : European Medicines Agency Validates Bristol Myers Squibb'..
AQ
05/22BRISTOL MYERS SQUIBB : European Medicines Agency Validates Bristol Myers Squibb'..
BU
05/21ACCELERON PHARMA : Announces Presentations on REBLOZYL at the 2020 American Soci..
AQ
05/20BRISTOL MYERS SQUIBB : Research at EHA 2020 Demonstrates Continued Advances Acro..
BU
05/19BRISTOL MYERS SQUIBB CO : Other Events, Financial Statements and Exhibits (form ..
AQ
05/18BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo + Yervo..
AQ
05/18BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
AQ
05/15BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo® (nivol..
BU
05/15BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
BU
05/14BRISTOL MYERS SQUIBB : Opdivo Plus Yervoy with Limited Chemotherapy Significantl..
AQ
05/14BRISTOL MYERS SQUIBB : and bluebird bio Provide Regulatory Update on Idecabtagen..
AQ
05/14BRISTOL MYERS SQUIBB : Three-Year Data from CheckMate -227 Confirm Durable, Long..
AQ
05/13BRISTOL MYERS SQUIBB AND BLUEBIRD BI : to Present Updated Positive Results from ..
BU
05/13BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Limited ..
BU
05/13BRISTOL MYERS SQUIBB : Three-Year Data from CheckMate -227 Confirm Durable, Long..
BU
05/13BRISTOL MYERS SQUIBB : and bluebird bio Provide Regulatory Update on Idecabtagen..
BU
05/12BRISTOL MYERS SQUIBB : to Take Part in the UBS Virtual Global Healthcare Confere..
BU
05/12BRISTOL MYERS SQUIBB : GRYT Health and Bristol Myers Squibb Team Up to Launch CO..
BU
05/11BRISTOL MYERS SQUIBB : Research at ASCO Demonstrates Diverse Approaches in Treat..
BU
05/07BRISTOL MYERS SQUIBB : 2019-2020 Product Sales Summary
PU
05/07BRISTOL MYERS SQUIBB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
05/07BRISTOL MYERS SQUIBB CO : Results of Operations and Financial Condition, Financi..
AQ
05/07BRISTOL-MYERS : 1Q Earnings Snapshot
AQ
05/07BRISTOL MYERS SQUIBB : Reports Strong First Quarter 2020 Financial Results
BU
05/06BRISTOL MYERS SQUIBB : Provides Update on Biologics License Application (BLA) fo..
BU
05/04BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Re..
AQ
05/01BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration (FDA) Accepts for Prior..
BU
05/01BRISTOL MYERS SQUIBB : Reblozyl Receives Positive CHMP Opinion for the Treatment..
AQ
04/30BRISTOL MYERS SQUIBB : Reblozyl (luspatercept) Receives Positive CHMP Opinion fo..
BU
04/27BRISTOL MYERS SQUIBB : Defendant Seeks Rehearing En Banc On Seventh Circuit's De..
AQ
04/21Bristol Myers Squibb and Exelixis Announce Positive Topline Results from Pivo..
AQ
04/21Ono and Takeda Announce Results from Phase 3 CheckMate -9ER Study for Opdivo ..
AQ
04/21BRISTOL MYERS SQUIBB : Announces Positive Topline Result from Pivotal Phase 3 Tr..
AQ
04/20United Airlines, Lennox fall; Bristol-Myers, M&T Bank rise
AQ
04/20BRISTOL MYERS SQUIBB : Announces Positive Topline Result from Pivotal Phase 3 Tr..
BU
04/20BRISTOL MYERS SQUIBB : and Exelixis Announce Positive Topline Results from Pivot..
BU
04/14BRISTOL MYERS SQUIBB CO : Other Events, Financial Statements and Exhibits (form ..
AQ
04/14BRISTOL MYERS SQUIBB : Announces Virtual 2020 Annual Meeting of Shareholders
BU
04/09BRISTOL MYERS SQUIBB : Announces Acceptance of U.S. and EU Regulatory Filings fo..
AQ
04/08BRISTOL MYERS SQUIBB : Announces Acceptance of U.S. and EU Regulatory Filings fo..
BU
04/07UPDATED STATEMENT : Bristol Myers Squibb on Coronavirus (COVID-19)
PU
04/07BRISTOL MYERS SQUIBB : Expands Patient Support Programs to Help Newly Uninsured ..
BU
04/06BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Reblozyl, the ..
AQ
04/03BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration (FDA) Approves Reblozyl..
BU
04/01BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
AQ
03/31BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
BU
03/31CYTOMX THERAPEUTICS : Announces Milestone Achievement in AbbVie CD71 Partnership..
AQ
03/30BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion Recommending Approval of Z..
AQ
03/27BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion Recommending Approval of Z..
BU
03/27BRISTOL MYERS SQUIBB : ONO and BMSKK Submit Supplemental Application for Opdivo ..
AQ
03/27BRISTOL-MYERS SQUIBB COMPANY : - New England Journal of Medicine Publishes Resul..
AQ
03/27BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
AQ
03/26Signet Jewelers, Bristol-Myers rise
AQ
03/26BRISTOL MYERS SQUIBB : BeiGene Announces Supply Update for ABRAXANE in China
AQ
03/26BRISTOL MYERS SQUIBB : New England Journal of Medicine Publishes Results from Pi..
BU
03/26BRISTOL MYERS SQUIBB : to Announce Results for First Quarter 2020 on May 7, 2020
BU
03/26BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
BU
03/25BRISTOL MYERS SQUIBB CO : Other Events, Financial Statements and Exhibits (form ..
AQ
03/24CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
AQ
03/23BRISTOL MYERS SQUIBB : Postpones April 2, 2020 Investor Day
BU
03/21UPDATED STATEMENT : Bristol Myers Squibb on Coronavirus (COVID-19)
PU
03/18BRISTOL MYERS SQUIBB : Appoints Elizabeth Mily as Executive Vice President, Stra..
BU
03/17BRISTOL MYERS SQUIBB : Updated Statement, Bristol Myers Squibb on Coronavirus
AQ
03/16UPDATED STATEMENT : Bristol Myers Squibb on Coronavirus (COVID-19)
PU
03/12BRISTOL MYERS SQUIBB CO : Financial Statements and Exhibits (form 8-K)
AQ
03/12STATEMENT : Bristol-Myers Squibb on Coronavirus (COVID-19)
PU
03/12BRISTOL-MYERS SQUIBB COMPANY : - U.S. Food and Drug Administration Approves Opdi..
AQ
03/12ANOTHER COURT TAKES A BITE OUT OF FO : Plaintiffs Must Bring Nationwide Class Cl..
AQ
03/11BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo® (nivol..
BU
1  2  3  4  5  6  7  8  9  10Next